InvestorsHub Logo
Followers 14
Posts 1735
Boards Moderated 0
Alias Born 01/21/2014

Re: Pip611 post# 164

Monday, 08/29/2016 2:45:31 PM

Monday, August 29, 2016 2:45:31 PM

Post# of 1990
No. I think they are estimating early 2017. Send John an email, unlike another company we know, he is very responsive.

John D. Menditto
Vice President, Corporate Communications and Investor Relations
Argos Therapeutics, Inc. (NASDAQ: ARGS)
O: 919.908.0687
M: 732.614.9041
E: jmenditto@argostherapeutics.com

Argos_RGB.png

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.